Viewing Study NCT00055120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-03-10 @ 1:09 AM
Study NCT ID: NCT00055120
Status: COMPLETED
Last Update Posted: 2014-10-15
First Post: 2003-02-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None AIDS-Related Opportunistic Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti-HIV Agents View
None Disease Progression View
None Drug Administration Schedule View
None Viral Load View
None HIV-1 View
None Treatment Outcome View
None Survival Analysis View
None Treatment Naive View